Back to Search
JACK RAMAGE, MD
MD
Gastroenterology Physician
NPI: 1841263944IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
2013-00253(NC)
Education
MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE
Class of 1997
Research & Publications (20)
The use of reverse immunology to identify HLA-A2 binding epitopes in Tie-2.
PMID 16408213·Cancer Immunol Immunother·2006
7-preclinical
Comparison of the immune response to a self antigen after DNA immunisation of HLA*A201/H-2Kb and HHD transgenic mice.
PMID 15068856·Vaccine·2004
4-observational
Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2.
PMID 15069689·Int J Cancer·2004
7-preclinical
The diphtheria toxin/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells.
PMID 12479856·Leuk Res·2003
4-observational
Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.
PMID 19458024·Endocr Relat Cancer·2009
4-observational
Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases.
PMID 19224519·Br J Surg·2009
4-observational
Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma.
PMID 18097130·Neuroendocrinology·2008
8-other
Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach.
PMID 17689070·Eur J Cancer·2007
8-other
Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study.
PMID 16984503·Aliment Pharmacol Ther·2006
3-trial
Complement decay accelerating factor (DAF)/CD55 in cancer.
PMID 16485129·Cancer Immunol Immunother·2006
8-other
Development of a disease-specific Quality of Life questionnaire module for patients with gastrointestinal neuroendocrine tumours.
PMID 16412628·Eur J Cancer·2006
8-other
Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.
PMID 16003753·Int J Cancer·2006
8-other
Development of cancer vaccines to activate cytotoxic T lymphocytes.
PMID 15934833·Expert Opin Biol Ther·2005
6-review
A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures.
PMID 16279894·Am J Gastroenterol·2005
4-observational
Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease.
PMID 15947551·Eur J Gastroenterol Hepatol·2005
8-other
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.
PMID 15888809·Gut·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 5 locations total
- Address
- 5145 S College Rd
Wilmington, NC 28412 - Phone
- (910) 763-5182
Locations (5)
Practice Location
5145 S College Rd, Wilmington, NC
(910) 763-5182
Practice Location
7420 Market St, Wilmington, NC
(910) 763-5182
Practice Location
1960 S 16th St, Wilmington, NC
(910) 763-5182
Practice Location
1520 PHYSICIANS DR, WILMINGTON, NC
(910) 662-8300
Practice Location
1520 PHYSICIANS DR, WILMINGTON, NC
(910) 763-5182
Quick Facts
- NPI
- 1841263944
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 5
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile